Effects of guanylyl cyclase and protein kinase G inhibitors on vasodilatation in non-tolerant and tolerant bovine coronary arteries

European Journal of Pharmacology

Volumn 370, Issue 1, 1999, Pages 39-46

  De La Lande, Ivan S ^a   Stafford, Irene ^a   Horowitz, John D ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Coronary artery, bovine; Glyceryl trinitrate; Guanylyl cyclase soluble; Protein kinase G; S Nitroso N acetylpenicillamine; Tolerance

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 (4 CHLOROPHENYLTHIO) CYCLIC GMP; 8 BROMOGUANOSINE 3',5' MONOPHOSPHOROTHIOATE; BRADYKININ; CYCLIC GMP DEPENDENT PROTEIN KINASE; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; ISOPRENALINE; N ACETYL S NITROSOPENICILLAMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CATTLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CROSS TOLERANCE; DRUG EFFECT; DRUG TOLERANCE; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CATTLE; CORONARY VESSELS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DRUG INTERACTIONS; DRUG TOLERANCE; ENZYME INHIBITORS; GUANYLATE CYCLASE; MUSCLE, SMOOTH, VASCULAR; NITROGLYCERIN; OXADIAZOLES; PENICILLAMINE; PROTEIN KINASE INHIBITORS; QUINOXALINES; S-NITROSO-N-ACETYLPENICILLAMINE; THIONUCLEOTIDES; VASODILATION; VASODILATOR AGENTS;

EID: 0032922494     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00092-8     Document Type: Article

References (28)

1. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
2. Brien J.F., McLaughlin B.E., Breedon T.H., Bennett B.M., Nakatsu N., Marks G.S. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta. J. Pharmacol. Exp. Ther. 237:1986;608-614.
3. Brooks A., Majewski H. The cyclic GMP inhibitor Rp-8-Br-cGMPS differentially inhibits the vasodilator effects of GTN, SNP and S-nitroso-N-acetylpenicillamine in rat aorta. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 2:1995;41.
4. Brunner F., Schmidt K., Nielsen E.B., Mayer B. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J. Pharmacol. Exp. Ther. 277:1996;48-53.
5. Butt E., Van Bemmelen M., Fischer L., Walter U., Jastorff B. Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine-3′,5′-monophosphorothioates. FEBS Lett. 263:1990;47-50.
6. De la Lande I.S., Philp T., Stafford I., Horowitz J.D. Lack of inhibition of glyceryl trinitrate by diphenyleneiodonium in bovine coronary artery. Eur. J. Pharmacol. 314:1996;347-350.
7. De la Lande I.S., Stafford I., Horowitz J.D. Heterogeneity of glyceryl trinitrate response in isolated bovine coronary arteries. Eur. J. Pharmacol. 318:1996;65-71.
8. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48:1995;184-188.
9. Henry P.J., Drummer O.H., Horowitz J.D. S-Nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators. Br. J. Pharmacol. 98:1989;757-766.
10. Henry P.J., Horowitz J.D., Louis W.J. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade. J. Pharmacol. Exp. Ther. 248:1989;762-768.
11. Holzmann S., Kukovetz W.R., Windischhofer W., Paschke E., Graier W.F. Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. J. Cardiovasc. Pharmacol. 23:1994;747-756.
12. Kawamoto J.H., McLaughlin B.E., Brien J.F., Marks G.S., Nakatsu K. Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilatation. J. Cardiovasc. Pharmacol. 15:1990;714-719.
13. Kowaluk E.A., Fung H.-L. Dissociation of nitrovasodilator-induced relaxation from cyclic GMP levels during in vitro nitrate tolerance. Eur. J. Pharmacol. 176:1990;91-95.
14. Kukovetz W.R., Holzmann S. Mode of action of nitrates with regard to vasodilatation and tolerance. Z. Kardiol. 75(3):1986;8-11. Suppl.
15. Kukovetz W.R., Holzmann S. Mechanisms of nitrate-induced vasodilatation and tolerance. Eur. J. Clin. Pharmacol. 38(1):1990;S9-S14. Suppl.
16. Laight D.W., Carrier M.J., Anggard E.E. Investigation of role for oxidant stress in vascular tolerance development to glyceryl trinitrate in vitro. Br. J. Pharmacol. 120:1997;1477-1482.
17. G-monomethyl-L-arginine, and endothelin-1. J. Cardiovasc. Pharmacol. 28:1996;418-424.
18. Munzel T., Sayegh H., Freeman B.A., Tarpey M.M., Harrison D.G. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. J. Clin. Invest. 95:1995;187-194.
19. Rapoport R.M., Waldman S.A., Ginsburg R., Molina C.R., Murad F. Effects of glyceryl trinitrate on endothelium-dependent and -independent relaxation and cyclic GMP levels in rat aorta and human coronary artery. J. Cardiovasc. Pharmacol. 10:1987;82-89.
20. Romanin Chr., Kukovetz W.R. Tolerance to nitroglycerin is caused by reduced guanylate cyclase activation. J. Mol. Cell. Cardiol. 21:1989;41-48.
21. Schrammel A., Behrends S., Schmidt K., Koesling D., Mayer B. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol. 50:1996;1-5.
22. Sellke F.W., Myers P.R., Bates J.N., Harrison D.G. Influence of vessel size on the sensitivity of porcine coronary vessels to nitroglycerin. Am. J. Physiol. 258:1990;H515-H520. Heart Circ. Physiol. 27.
23. Smith M.P., Humphrey S.J., Kerr S.W., Mathews W.R. In vitro vasorelaxant and in vivo cardiovascular effects of S-nitrosothiols: comparison to and cross-tolerance with standard nitrovasodilators. Methods Find. Exp. Clin. Pharmacol. 16(5):1994;323-335.
24. Tadjkarimi S., O'Neil G.S., Luu T.N., Allen S.P., Schyns C.J., Chester A.H., Yacoub M.H. Comparison of cyclic GMP in human internal mammary artery and saphenous vein: implications for coronary artery bypass graft patency. Cardiovasc. Res. 26:1992;297-300.
25. Van der Zypp A., Majewski H. Effect of cGMP inhibitors on the actions of nitrodilators in rat aorta. Clin. Exp. Pharmacol. Physiol. 25:1998;38-43.
26. Waldman S.A., Rapoport R.M., Ginsburg R., Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem. Pharmacol. 35:1986;3525-3531.
27. Zhang C.L., De la Lande I.S., Stafford I., Horowitz J.D. S-Nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery. Eur. J. Pharmacol. 252:1994;299-304.
28. Zhuo M., Hu Y., Schultz C., Kandel E.R., Hawkins R.D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature. 368:1994;635-639.